Table 2.

Means and standard deviations of outcome variables related to adiposity and health at baseline and follow-up visits

	Baseline	Change from baseline at M6	Change from baseline at M12	Change from baseline at M18	Change from baseline at M24
Weight (kg)	93.0(15.4)	−7.7(5.7)	−7.8(7.4)	−6.4(7.7)	−4.9(7.7)
Waist circumference (cm)	103.6(13.1)	−7.5(6.1)	−8.1(7.7)	−7.5(7.9)	−6.3(7.9)
Body fat*	37.3(6.8)	−3.0(2.8)			−2.3(3.4)
Systolic BP (mmHg)	119.5(13.5)	−2.7(9.9)	−3.6(10.9)		−1.9(11.0)
Diastolic BP (mmHg)	75.4(9.4)	−2.2(7.2)	−2.2(7.5)		−1.2(7.8)
Glucose (mg/dL)	92.2(14.0)	−2.5(9.0)			1.9(8.8)
Insulin (lU/mL)	12.1(7.6)	−2.8(6.7)			−1.4(6.6)
LDL cholesterol (mg/dL)	124.8(31.6)	−6.1(24.7)			−4.6(27.4)
HDL cholesterol (mg/dL)	49.1(14.4)	1.4(7.1)			4.9(7.6)
Triglycerides (mg/dL)	143.6(86.2)	−32.4(61.7)			−29.0(67.3)

The sample size N is 652–657 at baseline, 593–633 at Month 6, 578–582 at Month 12, 515–525 at Month 18, and 502–567 at Month 24

^*Body fat was measured in the subsample group with sample size of 358/309/223 for baseline/Month 6/Month 24. BP Blood Pressure, LDL low-density lipoprotein, HDL high-density lipoprotein